BL-S 640 (
) is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. The compound is well absorbed parenterally and orally by rodents and is effective by either route in the treatment of various experimental infections of mice. Biological and physicochemical properties of BL-S 640 were compared with those of four cephalosporins used clinically in the United Statesnamely, cephalothin, cephaloridine, cefazolin, and cephalexin. Antibacterial spectrum and other properties determined in vitro are the subject of the present paper; pharmacokinetics and therapeutic efficacy in rodents will be discussed in a companion paper (3) . Bacteria. The organisms, 612 strains of gram-negative and 177 strains of gram-positive species, preponderantly of recent clinical origin, were obtained from -numerous sources of broad geographical distribution. The organisms were stored as follows: suspensions of Neisseria gonorrhoeae in liquid nitrogen; Haemophilus influenzae, Neisseria meningitidis, Vibrio cholerae, Pasteurella multocida, Streptococcus pneumoniae, S. viridans, and S. pyogenes as lyophilized preparations; strains of the other organisms as a dry film on porcelain beads (insulators, Honeywell Inc.) (1) .
Antibiotic spectrum. The growth inhibitory activity of BL-S 640 and the control compounds was determined on solid medium by the antibiotic dilution technique. Except for Haemophilus and Neisseria, Mueller-Hinton medium (Difco) was used in these assays. For fastidious organisms, i.e., Streptococcus, Listeria, Pasteurella, Bordetella, and Vibrio, the medium was supplemented with 4% defibrinated sheep blood. The antibiotic susceptibility of Haemophilus and Neisseria was determined in GC Medium Base (BBL) supplemented with 1% hemoglobin (BBL) and 1% Isovitalex (BBL).
Ovemight broth cultures or an exponentially growing culture (Neisseria) served as the source of inoculum. A volume of approximately 0.003 ml of the undiluted or diluted culture was applied to the surface of the antibiotic-containing agar plates with the inoculator of Steers et al. (8) . Cultures of Neisseria, S. pneumoniae, S. viridans, and S. pyogenes were used without dilution; those of all other organisms were diluted 100-fold. The inoculum contained 103 viable cells of Neisseria, 105 of S. pneumoniae and S. pyogenes, 106 of S. viridans, and 10' of all other species. The culture plates were incubated at 37 C either overnight or for 24 h (Haemophilus), and the minimum inhibitory concentration, i.e., the lowest concentration of antibiotic that prevents visible growth, was recorded.
Effect of inoculum size. The effect of the initial cell concentration on the growth inhibitory activity of the cephalosporins was assessed by using three inocula, containing 106, 104, and 102 viable cells.
Bactericidal activity. Effect on viability was determined in medicated Mueller-Hinton broth (Difco). An inoculum of 104 cells was incubated ovemight at 37 C with various concentrations of antibiotic in 1 ml of broth. The number of cells remaining viable was determined by plating 0.1 ml of culture on MuellerHinton medium. The minimum bactericidal concentration was defined as the lowest concentration of antibiotic giving a count of less than 10 colonies per plate. (4) with the following modifications: gelatin was omitted and the buffer was adjusted to pH 7.0. The extracts of gram-negative organisms were obtained by sonic disruption of cell suspensions, followed by the removal of cell debris by centrifugation. The preparations were stored at -20 C for extended periods of time without significant loss of,B-lactamase activity. Staphylococci, grown in the presence of methicillin, were extracted with acetone and ether, and the resulting preparations were stored at 4 C.
Binding to plasma proteins. The degree of binding to human plasma proteins was estimated by means of the antibiotic diffusion technique of Scholtan and Schmid (6) . The assays were performed in 95% pooled human plasma. The range of cephalosporin concentrations was as follows: 2 to 50 gg/ml for BL-S 640 and cephalexin; 1 to 20 gg/ml for cephalothin; 0.5 to 5 gg/ml for cephaloridine; and 4 to 100 ,gg/ml for cefazolin.
Stability in solution. Stability at 37 C was determined at pH 2.0 in 0.002 M citric acid-hydrochloride buffer, and at pH 7.4 in 0.005 M barbital (BL-S 640, cephalexin), or 0.005 M phosphate buffer (cephalothin, cephaloridine, cefazolin, cephalexin). The initial antibiotic concentration was 0.2 mg for cephalothin, 0.6 mg for cefazolin, and 2 to 4 mg for the other cephalosporins. Residual antibiotic activity was determined periodically over a 24-h period by a turbidimetric assay procedure or by an antibiotic diffusion technique (cephalothin).
RESULTS
Antibiotic spectrum. The growth inhibitory activity of BL-S 640 and the four control cephalosporins is illustrated in Fig. 2 to 4 and Table 1 .
Against 96 strains of Escherichia coli, BL-S 640 was two to four times more active than cephaloridine, cephalexin, and cephalothin but only half as active as cefazolin (Fig. 2a) . Against Klebsiella, BL-S 640 was nearly twice as active as cefazolin and about four times as active as the other three cephalosporins (Fig. 2b) . At an antibiotic concentration of 16 gg/ml, BL-S 640 inhibited 40%, whereas the control compounds inhibited a negligible percentage of the Enterobacter strains (Fig. 2c) . Proteus mirabilis was four to eight times more susceptible to BL-S 640 than to the control compounds (Fig. 2d) . Moreover, all strains were inhibited by 16 jig/ml of BL-S 640, whereas the other cephalosporins failed to inhibit all 42 strains even at a concentration of 125 jig/ml. BL-S 640 was more active than the other cephalosporins against 12 of the 17 strains of Proteus vulgaris (Fig. 2e) . The remaining five strains were highly resistant to all cephalosporins. Four of the fifteen strains of Proteus morganii were inhibited by 8 g.of BL-S 640 per ml, but all strains were highly resistant to the control compounds (Fig. 2f) . At an antibiotic concentration of 16 ,ug/ml, slightly more than half of the Proteus rettgeri strains were inhibited by cefazolin, and nearly half were inhibited by BL-S 640 (Fig. 2g) . The other compounds were significantly less active. Against Salmonella and Shigella, BL-S 640 was more active than the control cephalosporins by about two-to eightfold (Fig. 3a and b) . Over 50% of the Providencia stuartii strains were inhibited by 16 ,g of either BL-S 640 or cefazolin per ml (Fig. 3c) . At the same concentration, cephalexin inhibited 17%, and cephalothin and cephaloridine inhibited less than 10% of the strains. Although most strains of H. influenzae, including seven ampicillin-resistant strains, were more susceptible to cephalothin than to BL-S 640, the latter inhibited the growth of all 24 strains at a lower concentration (4 Ag/ml) than did cephalothin (8 ,ug/ml) (Fig. 3d) . N. gonorrhoeae was about equally susceptible to BL-S 640, cephalothin, and cefazolin (Fig. 3e ), but N. meningitidis was most susceptible to BL-S 640 (Fig. 3f) . Edwardsiella tarda, Arizona hinshawii, Erwinia sp., V. cholerae, P. multocida, and five of twelve strains of Alcaligenes sp. were susceptible to all cephalosporins (Table 1) . Of the remaining strains of Alcaligenes, two were susceptible to BL-S 640 and cephalexin only, and five were susceptible to none of the cephalosporins. BL-S 640 alone was highly effective against four strains of Citrobacter sp. The fifth strain of Citrobacter and all strains of Serratia marcescens and Pseudomonas aeruginosa were resistant to the five compounds.
BL-S 640 was more active than cephalexin but less active than cefazolin, cephalothin, and particularly cephaloridine against S. aureus ( Fig. 4a and b) . Nevertheless, all strains were inhibited by 2 ,ug of BL-S 640 per ml. The relative activities of the five cephalosporins against S. pneumoniae and S. viridans paralleled those seen with staphylococci ( Fig. 4c and  d) . All pneumococcal strains were inhibited by 0.25 ,ug of BL-S 640 per ml, and all strains of S. viridans were inhibited by 2 ,ug of BL-S 640 per ml. S. pyogenes was highly susceptible to BL-S 640, which inhibited all strains tested at a concentration of 0.063 ,ug/ml (Fig. 4e) . By contrast, at 16 ,ug/ml, BL-S 640 inhibited only half of the strains of Streptococcus faecalis, a species relatively insensitive to cephalosporins (Fig. 4f) . Listeria monocytogenes was resistant VOL. 7, 1975 on to cephalexin but susceptible to BL-S 640, affected in a similar fashion the growth inhibicephalothin, cephaloridine, and cefazolin tory activity of BL-S 640 and of the control (Table 1) . compounds (Table 2) . Thus, when the inoculum Effect of inoculum size. Variations in the was increased from 102 to 10 organisms, the initial cell concentration of Enterobactericaeae activity of all cephalosporins generally declined slightly to moderately against strains of E. coli, K. pneumoniae, and P. mirabilis, and considerably against strains of Enterobacter cloacae, Hafnia alvei, and P. rettgeri. BL-S 640 and three of the control cephalosporins were similarly affected in their activity by a variation in the inoculum of P. vulgaris strains. The effect of inoculum on the susceptibility of staphylococci to cephalosporins is illustrated in Table 3 . The susceptibility of strains that lack penicillinase varied little with initial cell concentration. Penicillinase-producing strains, however, were not homogeneous in this respect.
With some strains, cell concentration affected only slightly the growth inhibitory activity of the cephalosporins, except cephaloridine; with others, the effect was marked except on cephalothin.
Bactericidal activity. BL-S 640 and the control compounds were effective bactericidal agents for strains of E. coli, K. pneumoniae, and P. vulgaris (Table 4) . With the exception of cephalexin, they were also very effective against strains of P. mirabilis. Against most strains of E. cloacae, however, the growth inhibitory activity itself was low; hence, no significant bacte- Stability in solution at 37 C. At pH 2.0, the half-life of BL-S 640 and cephalexin was greater than 24 h. At pH 7.4, the half-life of BL-S 640 activity was 6 h, and that of the other cephalosporins was greater than 24 h. DISCUSSION BL-S 640 compared favorably with four cephalosporins currently in clinical use when tested against a broad spectrum of bacteria. The compound was more active than the control cephalosporins against most major gram-negative and some gram-positive pathogenic species. Moreover, the antibacterial spectrum of BL-S 640 includes strains of Enterobacter, P. morganii, P. rettgeri, and P. stuartii, species generally resistant to the other cephalosporins. In most instances, BL-S 640 and the four control compounds were similarly affected in their growth inhibitory activity by variations in the inoculum. BL-S 640 was also an effective bactericidal agent for strains of several species of Enterobacteriaceae. How these antibacterial properties translate into therapeutic efficacy is the subject of a subsequent paper (3).
